Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $11.59, but opened at $10.60. Anbio Biotechnology shares last traded at $10.9640, with a volume of 491 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Anbio Biotechnology has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on Anbio Biotechnology
Anbio Biotechnology Trading Down 5.7%
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Recommended Stories
- Five stocks we like better than Anbio Biotechnology
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
